No Detail Found!

Novel modified piperacillin inhibitors of penicillin-binding protein 3 (PBP3) and their intermolecular interactions

Author(s)
Nadine Mohammed Kamel Qalalweh Department of Pharmacy, Faculty of Pharmacy, Arab American University, P.O. Box 240 Jenin, 13 Zababdeh, Jenin, Palestine
Abstract
Background and Objective: Despite therise of antibiotic resistance, penicillin and the broader group of B-lactams have continued tobe the most crucial class of antibiotics. Penicillin-Binding Protein 3 (PBP3) in Pseudomonas aeruginosa is the specific molecule that B-lactam-based medicines target. The objective s to design and study several piperacillin derivativetso create novel antibacterial agents. Materials and Methods: Piperacillin derivatives were drawn using chem sketch and prepared using AutoDock 4.2.6 Tools. Molecular docking simulations were conducted on novel piperacillin derivatives and piperacillin (Control) against the 6r3xPDB protein. The AutoDock log files were analyzed to determine the lowest energy of binding (LEB) values for each ligand. Consequently, the conformer withthe most favorable binding enermagybye identified. Results: All of the proposed piperacillin derivatives displayed improvedbinding energies when compa rtoethde reference chemical piperacilliThni.s suggestthse potential for strongerinteractions between derivatives and proteins, resulting in an enhanced likelihood of biological effects. Compounds b, e andj,when used alongside piperacillin, showed similar binding sites inside the active site and have the potential for additional characterization. Conclusion: Compounds b, e andj are highly likely to exhibit inhibitory activity, indicating that they should be synthesized and tested for biological activity.
Publication Details
Page(s) 455-468
Published Journal: Pakistan Journal of Biological Sciences, Volume: 27, Issue: 9, Year: 2024

Request the full text from PASTIC

Keywords
molecular docking, Pseudomonas aeruginosa, piperacillin, Penicillins, PBP3, antibacterial drugs
References
Fymat .2017 .Antibiotics and antibiotic resistance. Biomed. J. Sci. Tech. Res, 1 : .
.2017 .. , 01 : .
Wang Z,Duan Y.,Huang Y. .2022 .. , : .
Infection . .-related antibacterial nanotherapeutic ~ strategies. Biomaterials, 280 : .
.2021 .. , 121249 : .
Miller EL .2002 .The penicillins: A review and update. , : .
Midwifery J. . .. , 47 : 426-434.
Egan AJF,Errington J.,Vollmer W. .2020 .Regulation of peptidoglycan synthesis and remodelling. Nat. Rev., : .
. .. , 18 : 446-460.
Vollmer W.,Joris B.,Charlier P.,Foster S. .2008 .Bacterial peptidoglycan (murein) hydrolases. , 32 : 259-286.
Bush K and P.A.,Bradford K and P.A. .2016 .B-Lactams and B-lactamase inhibitors: An overview. Cold Spring Harbor Perspect. Med, 8 : .
Patrick J.,Spencer J. .2009 .. , 9780199234479 : 752.
Sainsbury S,Bird L,Rao V.,Shepherd S.M. .2011 .Crystal structures of penicillin-binding protein 3 from Pseudomonas aeruginosa. Comparison of native andantibiotic-bound fo rJ. , 405 : 173-184.
Hui X.P,Q. X.P,- X.P .2000 .-thiadiazine derivatives. J. Chin. Chem. Soc., 47(3) : 1115-1119.
Maffuid M.,Koyioni C.D.,Torrice W.A.,Murphy W.A. .2021 .Design and evaluation of 1,2,3-dithiazoles and fused 1,2,4-dithiazines as anti-cancer agents. Bioorg. Med. Chem. Lett, 128078 : .
Majchrzak-Stiller B.,M. Buchholz I. Peters,Strotmann J.,J.Méhrke etal J. .2023 .Oxathiazinane derivatives display both antineoplastic and antibacterial activity: A structure activity study. J. Cancer Res. Clin. Oncol., 149 : 9071-9083.
Mohanty M.,Mohanty P.S. .2023 .Molecular docking in organic, inorganic, and hybrid systems: A tutorial review. Chem, 154 : 683-707.
Chio H.,Dottorini T.,Hirst J.D.,Stekel D.J. .2023 .Predicting bioactivity of antibiotic metabolites by molecular docking and dynamics. J. Mol. Graphics Modell,, 108508 : .
Han S,Tomaras A.P. .2010 .Structural basis for effectiveness of siderophore-conjugated monocarbams against clinically relevantstrains of Pseudomonasaeruginosa. Proc.Natl. Acad. Sci.US, 107 : 22002-22007.
Ren J,Males A.,D.I. A. .2016 .Crystal structures of penicillin-binding protein 3 in complexweitsh azlocillinand cefoperazone in both acylated and deacylated forms. FEBS Lett, 590 : 288-297.
0

Citations

0

Downloads

44

Views